Renuka Holdings PLC (COSE:RHL.N0000)
20.90
+1.00 (5.03%)
At close: Aug 1, 2025
Revance Therapeutics Market Cap
Renuka Holdings has a market cap or net worth of 3.89 billion as of August 1, 2025. Its market cap has increased by 52.53% in one year.
Market Cap
3.89B
Enterprise Value
9.64B
Revenue
14.17B
Ranking
n/a
PE Ratio
24.88
Stock Price
$20.90
Market Cap Chart
Since January 19, 2009, Renuka Holdings's market cap has increased from 404.31M to 3.89B, an increase of 862.01%. That is a compound annual growth rate of 14.67%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 3.89B | 15.03% |
Dec 31, 2024 | 3.38B | 43.09% |
Dec 29, 2023 | 2.36B | -6.47% |
Dec 30, 2022 | 2.53B | -23.79% |
Dec 31, 2021 | 3.32B | 124.62% |
Dec 31, 2020 | 1.48B | -21.93% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
John Keells Holdings | 434.43B |
Ceylon Tobacco Company | 288.38B |
Commercial Bank of Ceylon | 280.73B |
LOLC Holdings | 265.64B |
Distilleries Company of Sri Lanka | 212.52B |
Hatton National Bank | 204.71B |
LOLC Finance | 201.78B |
Melstacorp | 185.88B |